Robinson Ann, Hirode Grishma, Wong Robert J
Department of Medicine, Division of Gastroenterology and Hepatology, Alameda Health System, Highland Hospital, Oakland, CA, USA.
Toronto Centre for Liver Disease, University Health Network, Toronto General Hospital, University of Toronto, Canada.
J Clin Exp Hepatol. 2021 Mar-Apr;11(2):188-194. doi: 10.1016/j.jceh.2020.07.011. Epub 2020 Aug 8.
Disparities in timely referral to liver transplantation (LT) evaluation persist. We aim to examine race/ethnicity and insurance-specific differences in the Model for End-Stage Liver Disease (MELD) score at time of waitlist (WL) registration and its impact on WL survival.
We retrospectively evaluated U.S. adults listed for LT using 2005-2018 United Network for Organ Sharing LT registry. Multiple linear regression methods examined factors associated with MELD at listing, and Fine-Gray competing risks regression were used to analyze WL mortality.
Among 144,163 WL registrants (median age = 56 years, 65.3% male, 56.4% private insurance, 23.3% Medicare, 15.7% Medicaid), mean WL MELD at listing was higher in African Americans versus non-Hispanic whites (2.57 points higher, 95%CI: 2.40-2.74, < 0.001). Compared with patients with private insurance, adjusted mean WL MELD was higher among those with no insurance, Medicare, or Medicaid ( < 0.001 for all). After correcting for differences in MELD at listing, Asians had lower risk of WL death versus non-Hispanic whites (subhazard ratio (SHR): 0.92, 95% CI: 0.86-1.00, = 0.04), but no difference was observed in African Americans or Hispanics. Compared with patients with private insurance, higher risk of WL death was observed in patients with no insurance (SHR: 1.33, 95%CI: 1.14-1.56, < 0.001), Medicare (SHR: 1.20, 95%CI: 1.16-1.25, < 0.001), or Medicaid (SHR: 1.22, 95%CI: 1.17-1.27, < 0.001).
Higher MELD scores at listing among African Americans did not translate into increased WL mortality. Patients with Medicare, Medicaid, or uninsured had significantly higher WL mortality than privately insured patients, even after correcting for disparities in MELD scores at listing.
在及时转介进行肝移植(LT)评估方面仍存在差异。我们旨在研究种族/族裔以及保险类型在等待名单(WL)登记时终末期肝病模型(MELD)评分中的差异及其对WL生存率的影响。
我们使用2005 - 2018年器官共享联合网络LT登记处的数据,对登记等待LT的美国成年人进行回顾性评估。采用多元线性回归方法研究与登记时MELD相关的因素,并使用Fine - Gray竞争风险回归分析WL死亡率。
在144,163名WL登记者中(中位年龄 = 56岁,65.3%为男性,56.4%有私人保险,23.3%有医疗保险,15.7%有医疗补助),非裔美国人登记时的平均WL MELD高于非西班牙裔白人(高2.57分,95%CI:2.40 - 2.74,<0.001)。与有私人保险的患者相比,无保险、有医疗保险或有医疗补助的患者调整后的平均WL MELD更高(所有比较P<0.001)。在校正登记时MELD的差异后,亚洲人WL死亡风险低于非西班牙裔白人(亚风险比(SHR):0.92,95%CI:0.86 - 1.00,P = 0.04),但非裔美国人或西班牙裔中未观察到差异。与有私人保险的患者相比,无保险患者(SHR:1.33,95%CI:1.14 - 1.56,<0.001)、有医疗保险患者(SHR:1.20,95%CI:1.16 - 1.25,<0.001)或有医疗补助患者(SHR:1.22,95%CI:1.17 - 1.27,<0.001)的WL死亡风险更高。
非裔美国人登记时较高的MELD评分并未转化为更高的WL死亡率。有医疗保险、医疗补助或无保险的患者,即使校正了登记时MELD评分的差异,其WL死亡率仍显著高于有私人保险的患者。